Transcutaneous bilirubinometry.

Area of Science:

• Neonatal Medicine
• Medical Devices
• Diagnostic Tools

Background:

• Transcutaneous bilirubin monitoring (TcB) is a widely adopted non-invasive screening tool for estimating hyperbilirubinemia in newborns.
• TcB has evolved significantly over 35 years, with advancements in accuracy and data integration.

Purpose of the Study:

• To review the advancements and documented efficacy of transcutaneous bilirubin monitoring in clinical practice.
• To assess the current evidence regarding the impact of TcB on predicting and managing neonatal hyperbilirubinemia.

Main Methods:

• Review of technological improvements in TcB devices, including value reporting and chromophore correction.
• Analysis of studies demonstrating the agreement between TcB measurements and laboratory bilirubin levels.
• Evaluation of evidence supporting TcB's role in predicting and decreasing hyperbilirubinemia incidence.

Main Results:

• Modern TcB devices offer direct bilirubin values, improved accuracy through chromophore correction, and electronic health record integration.
• TcB screening shows good correlation with laboratory measurements and is effective in predicting and reducing subsequent hyperbilirubinemia.
• No evidence currently demonstrates that TcB screening improves long-term infant health outcomes.

Conclusions:

• Transcutaneous bilirubin monitoring is a valuable, advanced tool for non-invasively screening neonatal hyperbilirubinemia.
• TcB effectively aids in the early detection and management of jaundice, reducing its incidence.
• Further research is needed to establish the long-term benefits of TcB screening on infant outcomes.